SHERRIE O'CALLAGHAN: Open Payments
NPI 1043865587 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 52 payments from 26 companies in 2025. Trend: 2023 $3,715 · 2024 $1,808 · 2025 $1,308
Food & beverage: $1,212Education: $96
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $126 |
| Celgene Corporation | 4 | $123 |
| Incyte Corporation | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| SEAGEN INC. | 1 | $96 |
| Gilead Sciences, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
Products named: REBLOZYL, MONJUVI, ENHERTU, Trodelvy, OPDIVO, KEYTRUDA, Xospata, NINLARO.
Industry payments across FL — which companies pay providers there.
